EPL Ltd. (EPLL) reported strong growth across Europe and the EAP region amid the COVID-19 crisis. This was primarily led by an increase in market share and new customer additions. Operating profit was offset by sluggish performance in Oral Care in the AMESA region. 2QFY21 numbers were in line with our estimates, and we maintain our estimates for FY21. However, in the backdrop of the acquisition, we increase our earnings estimate for FY22/FY23E by 6%/3%. Maintain Buy....